Elekta AB (EKTA B) - Product Pipeline Analysis, 2017 Update

Summary

Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. Elekta products find applications the treatment of cancer using radio therapy and in diagnosis and treatment of brain disorders in hospitals, academic institutions, and specialist and satellite clinics throughout the world. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Elekta AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Elekta AB Company Overview 4
Elekta AB Company Snapshot 4
Elekta AB Pipeline Products and Ongoing Clinical Trials Overview 4
Elekta AB – Pipeline Analysis Overview 7
Business Description 7
Elekta AB - Key Facts 7
Elekta AB - Major Products and Services 9
Elekta AB Pipeline Products by Development Stage 12
Elekta AB Ongoing Clinical Trials by Trial Status 14
Elekta AB Pipeline Products Overview 16
Elekta Unity 16
Elekta Unity Product Overview 16
Elekta Unity Clinical Trial 17
Leksell Vantage Stereotactic System 18
Leksell Vantage Stereotactic System Product Overview 18
MOSAIQ Mobile 19
MOSAIQ Mobile Product Overview 19
MR-linac System 20
MR-linac System Product Overview 20
MR-linac System Clinical Trial 21
Next generation Gamma Knife 22
Next generation Gamma Knife Product Overview 22
Elekta AB - Key Competitors 23
Elekta AB - Key Employees 24
Elekta AB - Key Employee Biographies 25
Elekta AB - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Elekta AB, Recent Developments 29
Jul 28, 2017: Elektas MR-linac Featured in 21 Abstracts at 2017 AAPM Annual Meeting 29
Jul 28, 2017: Elekta to Highlight High Definition Dynamic Radiosurgery with Versa HD and Monaco at AAPM Annual Meeting 30
Jul 24, 2017: Elekta Introduces Advanced Cancer Treatment to Kingdom of Bhutan 31
Jul 14, 2017: Steven Wort appointed as Elekta’s Chief Operating Officer 31
Jul 13, 2017: Elekta to Implement Critical Manufacturing for Global Production Excellence 32
Jul 13, 2017: Installation of Elekta MR-linac initiated at Sunnybrook Health Sciences Centre 32
Jun 28, 2017: Parkinsons Disease Patients are First to be Treated With Elektas New Leksell Vantage Stereotactic System 33
Jun 26, 2017: Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions Within Selected Markets in Europe 34
Jun 22, 2017: Equicare Health and Elekta announce Vendor Interoperability Program partnership 34
Jun 22, 2017: First patient in Canada treated with Elekta’s Leksell Gamma Knife Icon 35
Appendix 36
Methodology 36
About GlobalData 38
Contact Us 38
Disclaimer 39

List Of Tables

Elekta AB Pipeline Products and Ongoing Clinical Trials Overview 4
Elekta AB Pipeline Products by Equipment Type 5
Elekta AB Pipeline Products by Indication 6
Elekta AB Ongoing Clinical Trials by Trial Status 6
Elekta AB, Key Facts 7
Elekta AB, Major Products and Services 9
Elekta AB Number of Pipeline Products by Development Stage 12
Elekta AB Pipeline Products Summary by Development Stage 13
Elekta AB Ongoing Clinical Trials by Trial Status 14
Elekta AB Ongoing Clinical Trials Summary 15
Elekta Unity - Product Status 16
Elekta Unity - Product Description 16
Elekta Unity - Clinical Study of Elekta Unity System for Spinal Metastasis 17
Leksell Vantage Stereotactic System - Product Status 18
Leksell Vantage Stereotactic System - Product Description 18
MOSAIQ Mobile - Product Status 19
MOSAIQ Mobile - Product Description 19
MR-linac System - Product Status 20
MR-linac System - Product Description 20
MR-linac System - Magnetic Resonance Imaging (MRI) for the Delineation of Organs at Risk (OAR) and Target Volumes in Lung Cancer Patients 21
MR-linac System - New Era in Cancer Treatment using Revolutionary Radiotherapy Machine 21
Next generation Gamma Knife - Product Status 22
Next generation Gamma Knife - Product Description 22
Elekta AB, Key Employees 24
Elekta AB, Key Employee Biographies 25
Elekta AB, Other Locations 26
Elekta AB, Subsidiaries 26
Glossary 37

List Of Figures

Elekta AB Pipeline Products by Equipment Type 5
Elekta AB Pipeline Products by Development Stage 12
Elekta AB Ongoing Clinical Trials by Trial Status 14

Fill The Form For Sample Request

There is no Reviews available